NCT03680131: Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis |
|
|
| Active, not recruiting | 2 | 126 | Canada, US | EB01 Cream Placebo, EB01 Cream 0.2%, EB01 Cream 1.0%, EB01 Cream 2.0% | Edesa Biotech Inc., JSS Medical Research Inc. | Allergic Contact Dermatitis | 12/22 | 03/23 | | |
